Arvinas, Inc. (ARVN)

NMS – Real Time Price. Currency in USD

8.89

-0.10 (-1.17%)

Market open: Aug 12, 2026, 3:53 PM EDT

8.99

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know

Arvinas (ARVN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

04.08.2026

Arvinas, Inc. (ARVN) Q2 2026 Earnings Call Transcript

04.08.2026

Arvinas Q2 Earnings Call Highlights

Arvinas NASDAQ: ARVN said it is concentrating resources on its early-stage oncology and neurology pipeline after reaching several strategic milestones in the first half of 2026, including FDA approval of VEPPANU, the first approved PROTAC degrader, and an out-licensing agreement for the product with Rigel Pharmaceuticals.

04.08.2026

Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates

Arvinas, Inc. (ARVN) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of a loss of $0.24 per share. This compares to a loss of $0.84 per share a year ago.

04.08.2026

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

– Secured the first-ever regulatory approval of a PROTAC (a type of heterobifunctional protein degrader ), VEPPANU, and successfully completed out-licensing to Rigel Pharmaceuticals – – Anticipates sharing clinical data from three Phase 1 programs - ARV-393, ARV-102 and ARV-027 - over the next 12 months – – Presented promising preclinical data for HPK1 degrader program (ARV-6723) demonstrating the potential to overcome immune checkpoint inhibitor resistance in solid tumors – – Company to host conference call today at 8:00 a.m. ET – NEW HAVEN, Conn.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
ARVN	Wells Fargo	Equal Weight	undefined >> undefined	August 4th 2026

Press releases

04.08.2026

Arvinas, Inc. (ARVN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arvinas, Inc. (ARVN)

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know

Arvinas, Inc. (ARVN) Q2 2026 Earnings Call Transcript

Arvinas Q2 Earnings Call Highlights

Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videos

No Data

Upgrades / Downgrades

Press releases

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know

Arvinas, Inc. (ARVN) Q2 2026 Earnings Call Transcript

Arvinas Q2 Earnings Call Highlights

Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videos

No Data

Upgrades / Downgrades

Press releases

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Search stocks

Arvinas, Inc. (ARVN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arvinas, Inc. (ARVN)

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know

Arvinas, Inc. (ARVN) Q2 2026 Earnings Call Transcript

Arvinas Q2 Earnings Call Highlights

Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videos

No Data

Upgrades / Downgrades

Press releases

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know

Arvinas, Inc. (ARVN) Q2 2026 Earnings Call Transcript

Arvinas Q2 Earnings Call Highlights

Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Videos

No Data

Upgrades / Downgrades

Press releases

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update